LumiraDx Limited Q4 2022 Earnings Call Transcript
LMDXDelisted Stock | USD 0.42 0.02 4.55% |
Slightly above 61% of LumiraDx's investor base is looking to short. The analysis of current outlook of investing in LumiraDx suggests that many traders are alarmed regarding LumiraDx's prospects. LumiraDx's investing sentiment can be driven by a variety of factors including economic data, LumiraDx's earnings reports, geopolitical events, and overall market trends.
LumiraDx |
Operator Good day and thank you for standing by. Welcome to the LumiraDx Fourth Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Read at insidermonkey.com
LumiraDx Fundamental Analysis
We analyze LumiraDx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LumiraDx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LumiraDx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
LumiraDx is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
LumiraDx Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LumiraDx stock to make a market-neutral strategy. Peer analysis of LumiraDx could also be used in its relative valuation, which is a method of valuing LumiraDx by comparing valuation metrics with similar companies.
Peers
LumiraDx Related Equities
FONR | Fonar | 0.87 | ||||
SHC | Sotera Health | 0.68 | ||||
BDSX | Biodesix | 0.68 | ||||
BNR | Burning Rock | 1.22 | ||||
ENZ | Enzo Biochem | 1.35 | ||||
XGN | Exagen | 3.88 | ||||
SERA | Sera Prognostics | 7.56 | ||||
DRIO | DarioHealth Corp | 12.50 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in LumiraDx Stock
If you are still planning to invest in LumiraDx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LumiraDx's history and understand the potential risks before investing.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |